05 Oct 2022
30 Sep 2022
In Iraq, a large proportion of coronavirus 2019 (COVID-19) patients were 1,340,000 confirmed cases as of June 7, 2021. The common symptoms of acute patients include cough, fever, shortness of breath and myalgia, joint pain, fatigue, gastrointestinal symptoms, and dyspepsia. Because there are only limited data and evidence available about the long-term effects in patients after recovery from infection with COVID-19, the aim of this study is to evaluate and determine the persistent symptoms in Iraqi patients after recovery from COVID-19. Hence, particular data on specific symptoms and infections associated with COVID-19 were obtained using a common standard questionnaire run by the researchers where the subjects (754) are asked to complete a form prepared for this purpose that indicated the absence or presence of symptoms. The results of these unique studies in Iraq showed that about 85.5% of people who recover from COVID-19 have at least one persistent symptom. The most common symptoms were joint pain, dyspnoea, chest pain, and cough. The results also showed other symptoms, though at lower incidence that the above, such as headache, heart palpitations, and hearing disorders had been noted. With respect to less common symptoms and those also considered important long-term complications, 191 (19.2%) of respondents had neurological problems, 163 (16.3%) had psychological problems, and 154 (15.4%) had skin rash and hair loss, where the durations of these persistent symptoms lasted from 1-6 months. In conclusion, the present study has shown that different persistent symptoms were common in recovered COVID-19 patients and were related to age and number of comorbidities present during the acute phase. Many COVID-19 patients were back to their normal physical health in one month however the majority of patients were symptoms-free from 1-6 months after COVID-19 onset.